vs

Side-by-side financial comparison of Envela Corp (ELA) and Inogen Inc (INGN). Click either name above to swap in a different company.

Envela Corp is the larger business by last-quarter revenue ($80.5M vs $68.6M, roughly 1.2× Inogen Inc). On growth, Envela Corp posted the faster year-over-year revenue change (66.6% vs 3.4%). Inogen Inc produced more free cash flow last quarter ($-1.9M vs $-3.7M). Over the past eight quarters, Envela Corp's revenue compounded faster (42.1% CAGR vs 4.2%).

Envela Corporation is a U.S.-based company that provides recommerce services aimed at extending product lifecycles and reducing resource consumption. The company operates through two primary segments: consumer and commercial.

Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.

ELA vs INGN — Head-to-Head

Bigger by revenue
ELA
ELA
1.2× larger
ELA
$80.5M
$68.6M
INGN
Growing faster (revenue YoY)
ELA
ELA
+63.2% gap
ELA
66.6%
3.4%
INGN
More free cash flow
INGN
INGN
$1.8M more FCF
INGN
$-1.9M
$-3.7M
ELA
Faster 2-yr revenue CAGR
ELA
ELA
Annualised
ELA
42.1%
4.2%
INGN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ELA
ELA
INGN
INGN
Revenue
$80.5M
$68.6M
Net Profit
$6.0M
Gross Margin
20.5%
51.4%
Operating Margin
9.4%
-13.6%
Net Margin
7.4%
Revenue YoY
66.6%
3.4%
Net Profit YoY
274.6%
EPS (diluted)
$0.22
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ELA
ELA
INGN
INGN
Q4 25
$80.5M
$68.6M
Q3 25
$57.4M
$79.1M
Q2 25
$54.9M
$79.2M
Q1 25
$48.3M
$68.5M
Q4 24
$48.3M
$66.3M
Q3 24
$46.9M
$74.9M
Q2 24
$45.3M
$74.4M
Q1 24
$39.9M
$63.1M
Net Profit
ELA
ELA
INGN
INGN
Q4 25
$6.0M
Q3 25
$3.4M
$-5.3M
Q2 25
$2.8M
$-4.2M
Q1 25
$2.5M
$-6.2M
Q4 24
$1.6M
Q3 24
$1.7M
$-6.0M
Q2 24
$1.6M
$-5.6M
Q1 24
$1.9M
$-14.6M
Gross Margin
ELA
ELA
INGN
INGN
Q4 25
20.5%
51.4%
Q3 25
22.8%
52.2%
Q2 25
22.6%
52.2%
Q1 25
24.8%
53.1%
Q4 24
23.1%
54.7%
Q3 24
24.4%
55.2%
Q2 24
25.1%
57.4%
Q1 24
25.9%
54.5%
Operating Margin
ELA
ELA
INGN
INGN
Q4 25
9.4%
-13.6%
Q3 25
7.3%
-9.0%
Q2 25
5.9%
-7.7%
Q1 25
6.5%
-11.2%
Q4 24
3.9%
-17.2%
Q3 24
4.3%
-10.4%
Q2 24
4.2%
-9.5%
Q1 24
5.9%
-25.8%
Net Margin
ELA
ELA
INGN
INGN
Q4 25
7.4%
Q3 25
5.8%
-6.7%
Q2 25
5.0%
-5.2%
Q1 25
5.2%
-9.0%
Q4 24
3.3%
Q3 24
3.6%
-8.0%
Q2 24
3.5%
-7.5%
Q1 24
4.8%
-23.1%
EPS (diluted)
ELA
ELA
INGN
INGN
Q4 25
$0.22
$-0.26
Q3 25
$0.13
$-0.20
Q2 25
$0.11
$-0.15
Q1 25
$0.10
$-0.25
Q4 24
$0.07
$-0.41
Q3 24
$0.06
$-0.25
Q2 24
$0.06
$-0.24
Q1 24
$0.07
$-0.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ELA
ELA
INGN
INGN
Cash + ST InvestmentsLiquidity on hand
$103.7M
Total DebtLower is stronger
$9.9M
Stockholders' EquityBook value
$67.1M
$192.2M
Total Assets
$96.0M
$298.6M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ELA
ELA
INGN
INGN
Q4 25
$103.7M
Q3 25
$106.5M
Q2 25
$103.7M
Q1 25
$118.9M
Q4 24
$113.8M
Q3 24
$105.7M
Q2 24
$97.9M
Q1 24
$19.8M
$107.4M
Total Debt
ELA
ELA
INGN
INGN
Q4 25
$9.9M
Q3 25
$12.5M
Q2 25
$13.0M
Q1 25
$13.2M
Q4 24
$13.5M
Q3 24
$13.8M
Q2 24
$14.3M
Q1 24
$14.6M
Stockholders' Equity
ELA
ELA
INGN
INGN
Q4 25
$67.1M
$192.2M
Q3 25
$61.1M
$197.2M
Q2 25
$57.8M
$199.5M
Q1 25
$55.1M
$198.0M
Q4 24
$52.7M
$173.9M
Q3 24
$51.1M
$185.4M
Q2 24
$50.2M
$187.6M
Q1 24
$49.3M
$191.9M
Total Assets
ELA
ELA
INGN
INGN
Q4 25
$96.0M
$298.6M
Q3 25
$90.9M
$307.0M
Q2 25
$82.7M
$312.0M
Q1 25
$79.7M
$308.4M
Q4 24
$77.9M
$296.2M
Q3 24
$77.4M
$306.2M
Q2 24
$73.8M
$308.9M
Q1 24
$74.7M
$315.6M
Debt / Equity
ELA
ELA
INGN
INGN
Q4 25
0.15×
Q3 25
0.20×
Q2 25
0.23×
Q1 25
0.24×
Q4 24
0.26×
Q3 24
0.27×
Q2 24
0.29×
Q1 24
0.30×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ELA
ELA
INGN
INGN
Operating Cash FlowLast quarter
$-3.5M
$-943.0K
Free Cash FlowOCF − Capex
$-3.7M
$-1.9M
FCF MarginFCF / Revenue
-4.6%
-2.8%
Capex IntensityCapex / Revenue
0.2%
1.4%
Cash ConversionOCF / Net Profit
-0.59×
TTM Free Cash FlowTrailing 4 quarters
$1.4M
$-13.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ELA
ELA
INGN
INGN
Q4 25
$-3.5M
$-943.0K
Q3 25
$2.4M
$2.2M
Q2 25
$2.6M
$4.3M
Q1 25
$1.1M
$-16.8M
Q4 24
$3.7M
$-3.0M
Q3 24
$3.4M
$7.0M
Q2 24
$-789.5K
$6.7M
Q1 24
$3.8M
$-4.7M
Free Cash Flow
ELA
ELA
INGN
INGN
Q4 25
$-3.7M
$-1.9M
Q3 25
$2.2M
$1.6M
Q2 25
$2.1M
$3.7M
Q1 25
$746.6K
$-17.1M
Q4 24
$3.2M
$-3.3M
Q3 24
$1.5M
$5.3M
Q2 24
$-1.3M
$6.6M
Q1 24
$3.3M
$-6.1M
FCF Margin
ELA
ELA
INGN
INGN
Q4 25
-4.6%
-2.8%
Q3 25
3.8%
2.0%
Q2 25
3.9%
4.6%
Q1 25
1.5%
-24.9%
Q4 24
6.7%
-5.0%
Q3 24
3.1%
7.1%
Q2 24
-2.9%
8.9%
Q1 24
8.4%
-9.6%
Capex Intensity
ELA
ELA
INGN
INGN
Q4 25
0.2%
1.4%
Q3 25
0.4%
0.7%
Q2 25
0.8%
0.9%
Q1 25
0.8%
0.4%
Q4 24
1.0%
0.5%
Q3 24
4.2%
2.2%
Q2 24
1.1%
0.1%
Q1 24
1.1%
2.1%
Cash Conversion
ELA
ELA
INGN
INGN
Q4 25
-0.59×
Q3 25
0.72×
Q2 25
0.94×
Q1 25
0.45×
Q4 24
2.34×
Q3 24
2.05×
Q2 24
-0.50×
Q1 24
1.99×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ELA
ELA

Consumer Segment$67.7M84%
Commercial Segment$12.8M16%

INGN
INGN

Other$36.1M53%
Non Us$32.5M47%

Related Comparisons